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Background: The prevalence of infertility and vitamin D deficiency is common in
Pakistan. Therefore, our study aims were to assess and compare Vitamin D;
25-hydroxyvitamin (25OHD) and reproductive hormone levels in male fertile and infertile
subjects with normal and abnormal sperm parameters. Furthermore, the study is aimed
to explore the association of 25OHD levels with these sperm parameters in a selected
population of Karachi, Pakistan.
Methods: The cross-sectional study was carried out from August 2016 till December
2017, 313 study subjects were recruited from an Infertile Clinic from Islamabad, Pakistan,
and the general population. First, we took the couples’ history of parenting and then
carried out a semen analysis and infertile and fertile male subjects were then subgrouped
into “normal” and “altered sperm parameter/s.” Forward linear regression was done for
selection of 25OHD as a significant predictor of sperm parameters.
Results: The median values of the total count, motility, morphology as well as serum
25OHD were significantly higher in the group with “normal” (186) as compared to subjects
(127) in “abnormal sperm parameters” group. The 25OHD levels were significantly high
in males with “normal sperm parameters”; 80.90 ± 23.33 nmol/L vs. “altered sperm
parameter/s,” 64.68 ± 24.21 nmol/L (mean ± SD) with p < 0.001. Serum testosterone
level had a significant positive correlation with 25OHD while LH had a significant negative
correlation with 25OHD (p < 0.001), and FSH level had a non-significant negative
correlation with 25OHD. Results of regression model showed one unit increase of motility
would give 0.15-unit positive significant impact on 25OHD; 20% variation in 25OHD was
explained by the total count, motility, and morphology, while the model was adjusted for
BMI.
Conclusion: The impact of 25OHD levels on sperm parameters can be emphasized
on the basis of detection of its high serum levels in “normal” subjects in both fertile as
well as infertile males in comparison to subjects that had altered sperm parameters; total
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sperm count, motility, and normal morphology. The considerably positive association
between 25OHD, testosterone, total count, motility, and morphology further accentuates
its impact on normal spermatogenesis and the male reproductive functions required for
acquiring fertility.
Keywords: infertility, vitamin D, 25OHD, testosterone, FSH, LH

INTRODUCTION

of male infertility to be 25–30%, by taking this probability we had
drawn a sample size of 323 patients at 95% confidence interval
with 5% margin of error by the given formula.

The existence of Vitamin D metabolizing enzymes and its
receptors in male and female reproductive tissues indicate a role
for vitamin D in human reproduction (1). The presence of the
Vitamin D receptor (VDR), CYP2R1, CYP27B1, and CYP24A1
on the head and mid-piece of human sperm specifies that there is
some role for Vitamin D 25OHD in sperm functionality, but that
function is not fully understood. The VDR and these enzymes
are also expressed in elongated spermatids, epididymis, seminal
vesicle, and prostate (2).
The importance of 25OHD in human reproductive physiology
has been further studied by proving the presence of the VDR
on human sperm and noticing a significant decrease in sperm
motility, total number of motile sperm, amount of sex hormone
binding globulin, and testosterone/estradiol ration in 25OHD
deficient males as compared to 25OHD sufficient males (3–5).
A recent study in Iran reported that almost half of the
study population had 25OHD insufficiency and deficiency.
Additionally, they reported no significant association between
25OHD and semen parameters and reproductive hormones in
normospermic men while it had a positive relationship with
sperm motility in the OAT cohort (6). Tirabassi et al. described
a positive and significant effect of 25OHD concentration on the
sperm motility (7). Another study reported that the deficient
levels of serum 25OHD were linked to worse sperm parameters
(8). Several studies have reported the positive correlation between
25OHD and free testosterone (FT) and total testosterone (TT)
levels among healthy men (9, 10), while a study reported no
significant correlation between 25OHD and sex hormones (11).
Evidently, the significance of the relationship between serum
25OHD levels and male fertility is inconclusive, but there is a
clear association. In a population such as ours in which 25OHD
deficiency is common, and about 20% suffer from infertility
(12, 13), there is a need to explore whether this deficiency or
insufficiency has an impact on normal reproductive function.
Our study aims were to compare 25OHD and reproductive
hormone levels in male fertile and infertile subjects with
normal and abnormal sperm parameters (sperm count/ejaculate,
motility, and morphology) and observe the association of
25OHD levels with these sperm parameters to assess the possible
role of 25OHD levels on normal reproductive functions thus
leading to fertility.

n=

e2

(1.96)2 (0.3) (0.7)
(0.05)2
= 323 whereα = Confidence interval, p
=

= Probibality of incidence and e = error Margin
A convenient sampling of 380 males was done, 67 subjects were
excluded on the basis of criteria enlisted in Figure 1, and a final
sample of 313 was achieved.

Study Protocol
The approval for this study was given by the Institutional Ethical
Review Board. All subjects were asked to complete written and
informed consent.

Inclusion Criteria
All male subjects with age ranging from 25 to 55 years during
the study period who consented to take part and were not
suffering any chronic disease or any endocrinal problems were
included. The fertile participants were recruited from the general
population. The group comprised of healthy males; without any
history of fertility problems and whose spouses conceived within
1 year of unprotected intercourse (14). In addition to the fertile
males, all the males referred to infertility clinic, were from couples
who had failed to conceive after 1 year of regular unprotected
intercourse, (14) with primary infertility and exception of female
cause of infertility were included (a detailed history about the
type and cause of infertility helped in exclusion of secondary
infertility in males and female causes of infertility).
The study population thus comprised of 135 fertile and
178 infertile male subjects. The general physical examination,
estimation of height, weight, and calculation of Body Mass
Index (BMI) was followed by examination of testis, epididymis,
vas deferens, and varicocele by (Valsalva maneuver). The
genitourinary ultrasound was then performed.

Exclusion Criteria
Subjects who had the female cause of infertility, suffered from
secondary infertility, had; cryptorchidism, testicular trauma,
orchitis, and testicular hypotrophy were excluded. Moreover,
subjects who were on 25OHD therapy, receiving testosterone
or thyroxin replacement therapy and calcium supplementation
were also eliminated. Subjects with cancer, epilepsy, diabetes,
parathyroid gland disease, hypertension, malabsorption, gastric
bypass, celiac disease, and inflammatory bowel disease and with
a poor general health status were also excluded.

SUBJECTS AND METHODS
Study Design and Population
The present cross-sectional study was carried out from August
2016 till December 2017 and 380 subjects were recruited. Before
starting this research, we had prior information on the prevalence
Frontiers in Endocrinology | www.frontiersin.org
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FIGURE 1 | Flow chart showing enrollment, selection and participation of subjects.

In order to avoid variation of semen analysis results obtained
from different laboratories, assigned laboratory technicians
performed fresh semen analysis of all patients. They were
requested to provide semen samples by masturbation after three
to five days of abstinence. All samples were saved in sterile
containers, and World Health Organization guidelines were
followed to examine the samples.
The fertility status of study participants in our study
was based on semen parameters according to (WHO criteria
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“2010”) i.e., “had total sperm number (TC) >39 million
per ejaculate, total sperm motility (Progressive and Nonprogressive) measured within 60 min of collection of more
than 40%, and %normal morphology (MORPH) of ≥ 4%
(15). The “normal sperm parameters” group included male
subjects who had TC >39 million per ejaculate, MOT > 40
% and MORPH of ≥ 4%. “altered sperm parameter group”
comprised subjects who had variation in at least one of the above
criteria.
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sufficient (50–125 nmol/L), insufficient (25–50 nmol/L), deficient
(<25 nmol/L)” (16).

In order to know the fertility status (sperm parameters) in
both fertile and infertile male subjects, we categorized both fertile
and infertile subjects further into normal (normozoospermia)
and altered sperm parameter/s. Therefore, “normal” in both
fertile and infertile subjects had total sperm count (TC) >39
million per ejaculate, total sperm motility (progressive and nonprogressive) more than 40% (measured within 60 min after
collection of sample), and normal morphology of ≥ 4%. The
subjects (both fertile and infertile) whose semen analysis showed
any abnormality in sperm parameters as defined by WHO criteria
(15), (i) TC < 39 million sperms per ejaculate (ii) <40% motility
measured within 60 min of collection, and (iii) <4% (or 5th
centile) comprised subgroup of abnormal sperm parameter/s.

Statistical Analysis
Data were stored and analyzed using IBM-SPSS version 23.0.
Medians and interquartile ranges were reported for sperm
parameters; mean comparison between two study groups was
performed using the Mann-Whiney U test. Pearson correlation of
vitamin D, 25OHD.was also done to see the direction of age, TC,
MOT, MORPH, and Rapid Linear Progression (RLP). Forward
Likelihood Ratio (LR) regression was done for the selection of
significant predictors of 25OHD. In the groups categorized on
the basis of cut off values of 25OHD mean values compared using
ANOVA, post hoc Tukey HSD test was then applied. All p-values
< 0.05 were taken as significant.

Procedures
Around ten milliliters of venous blood from the ante-cubital
vein was collected in the morning from study subjects.
Serum obtained by centrifugation of blood was stored at
−70◦ C until further analysis. Serum FSH was determined by
using a commercially available kit for Human FSH Enzyme
Immunoassay (Kit Cat. No KAPD1288 by DIA source Immuno
Assays S.A. Belgium). Serum LH estimation was made by using a
commercially available kit for Human LH Enzyme Immunoassay
(Kit Cat. No KAPD1289 by DIA source Immuno Assays S.A.
Belgium). Serum total testosterone was determined by using a
commercially available kit for Human Total Testosterone (TT)
Enzyme Immunoassay (Kit Cat. No 11-TESHU-E01 “in vitro
Diagnostic” the United States of America). For Elecsys FSH
immunoassay, the inter assay CV, and intra assay CV were <6
and <3%, respectively and for Elecsys LH immunoassay the inter
assay CV and intra assay CV were <6 and <5%, respectively. For
TT immunoassay, the inter assay CV and intra assay CV were
<6%.
The intra-assay and inter-assay coefficient of variation (CV)
for 25OHD was 2.7 and 4.3%, respectively. The lowest limit of
detection was 2.8 ng/ml. We adopted the “Institute of Medicine
cutoff points for vitamin D levels classifying serum levels into

RESULTS
On the basis of stratification done on sperm parameters in
the study, there were 186 normozoospermic males (normal
sperm parameter/s), and 127 subjects had one or more
than sperm parameters altered (“altered sperm parameters”).
Normozoospermic (93) male subjects were fertile and 93 reported
to be infertile. There was a significantly high proportion of
“altered sperm parameter/s” in infertile (85) as compared to
fertile subjects (42). The 25OHD levels were significantly high in
males with normal sperm parameters; 80.90 ± 23.33 nmol/L vs.
altered sperm parameter/s, 64.68 ± 24.21 nmol/L (mean ± SD)
with p < 0.001. Comparison of 25OHD levels in both groups is
shown in Figure 2A.
The comparisons of median and interquartile range of male
subjects with “normal” and “altered sperm parameters/s” in
Tables 1A,B shows that the median values of serum 25OHD were
significantly lower in the group which had altered TC/(MOT)
and/or MORPH. In accordance with that serum FSH, LH and
testosterone levels were significantly lower in subjects with

FIGURE 2 | Distribution of vitamin D between groups having “normal” and “altered sperm parameter/s.” (A) Box plot of median 25 and 75th percentiles showed
dissimilar distribution of vitamin D between normal and altered sperm parameters. (B) Comparison of Vitamin D among fertile and infertile groups having “normal” and
“altered sperm parameter/s.” Normal sperm parameters = total sperm count > 39 milion sperm per ejaculate, motility > 40%, and normal morphology ≥ 4%. Aitered
sperm parameter = total sperm count < 39 million sperm per ejaculate, motility < 40% and normal morphology < 4% (at least one parameter is altered).
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“altered sperm parameter/s” as compared to normozoospermic
(“normal sperm parameter”) group of subjects.
On the basis of 25OHD levels subjects 1(0.5%), 17(9.1%), and
168 (90.3%) were declared deficient, insufficient and sufficient
in “normal sperm parameter group” (16). In the “altered sperm
parameter/s” group, estimation of 25OHD levels showed; 4
(3.1%), 36 (28.3%), and 87 (68.5%) subjects labeled as deficient,
insufficient and sufficient.
The comparison of 25OHD (nmol/L, mean ±SD) in normal
and “altered sperm parameter/s” of fertile subjects was 99.64
± 13.86 vs. 90.60 ± 14.04 (p < 0.001). In infertile subjects
significantly high values of 25OHD (nmol/L, mean ±SD) was
observed in “normal” infertile; 62.15 ±13.86, in comparison
to 51.87 ± 16.77 in infertile “altered sperm parameter/s.” The
comparison is shown in Figure 2B.
Figure 3 represents significantly high TC, MOT and MORPH
in 25OHD sufficient group as compared to the other groups. All
sperm parameters were significantly compromised when males
had deficiency or insufficiency of 25OHD.
Table 2 reports the correlation value of 25OHD with all
Sperm Parameters and Male Reproductive Hormones. A positive
association of 35.1, 25, 42.9 and 30.8% was obtained for age, TC,
MOT, and MORPH, respectively. A strong positive correlation
of 0.637 was observed between testosterone (ng/ml) and 25OHD
with a significance level of <0.01 while LH had a significant
negative correlation with 25OHD (p < 0.001), and FSH level had
a non-significant negative correlation with 25OHD.

Table 3 depicts the results of the regression model obtained
for the factors (TC, MOT, and MORPH) that are influenced by
25OHD using the forward linear regression method. As observed,
one unit increase of 25OHD led to 1.37, 1.00, and 0.001 increases
in the TC, MOT, and MORPH, respectively, whereas RLP seemed
unaffected and was excluded due to the p-value of more than 0.05.
Adjusted R-square value suggests that 25OHD is responsible for
6, 18, and 0.1% of the variance of the total count, motility, and
morphology.

DISCUSSION
The present study found a significant decrease in 25OHD
levels in subjects that had altered sperm parameters; TC,
MOT, and MORPH. These results are similar to several
other studies (5, 17). Conversely, few studies have reported
contradictory results (4, 8, 18), and one of the reasons could
be that in most of the studies their all study participants
were healthy control from the general population as opposed
to our selected group of patients. However, we are unable
to find the exact pathophysiological mechanism of action of
25OHD that was responsible for abnormal sperm parameters,
thus causing infertility. Nevertheless, VDR is found in male
reproductive tissues such as human testis, ejaculatory tract, and
mature spermatozoa (2), and this indicates a role of 25OHD in
human reproduction. Recently, Fu et al. stipulate that 25OHD
deficiency reduces testicular weight and sperm quality; moreover,
there is suppression of testicular germ cell production and a
decline in mature seminiferous tubules percentage in mice. They
also reported that 25OHD deficiency reduces the enzymes for
testosterone synthesis and, consequently, serum, and testicular
testosterone levels were decreased (18).
The present study found a significantly positive association
between 25OHD and total sperm count and motility. Similar
results were obtained by other studies (3, 7). These results
are further supported by the findings of the VDR and
25OHD metabolizing enzymes in the sperm head and the male
reproductive tract. Low sperm motility has also been reported
with deficient or insufficient 25OHD levels (17, 18), which is
also evident in our findings. Hammoud et al. observed that low
25OHD levels were associated with decreased total sperm count
and progressive motile sperm count but did not affect sperm
concentration, progressive motility and normal morphology (4).
Literature indicates that 25OHD raises intracellular calcium
levels and motility of sperm; it also brings the acrosome reaction
in mature spermatozoa, and there was a positive association
between serum 25OHD levels and sperm motility (3). On the
basis of which it can be suggested that deficiency, as well as
insufficiency, disturb the sperm motility.
It is reported in the literature that quality and count of sperms
are dependent on many parameters such as optimal level of
enzymes, hormones, and antioxidants (19). Vitamin D 25OHD
level may not affect sperm production directly but can be a major
contributing factor when fertility is concerned.
In the present study, we observed a high sperm count in
subjects with sufficient levels of 25OHD. Zhu et al. reported

TABLE 1A | Comparison of study variables in groups characterized by normal
and abnormal sperm parameters.
Normal sperm
parameters
(186)
Median

Abnormal sperm
parameter/s
(127)

IQR

Median

IQR

P-value

Age (Yrs.)

36

8

34

9

0.025

Total sperm
count, (million
per ejaculate)

110

60

38

55

0.000

Motility (%)

71

5

45

55

0.000

RLP (%)

1

3

0

1

0.000

MORPH (%)

6

6

2

1

0.000

80.8

37.525

63.175

37.625

0.000

FSH mIU/ml

4

3.7635

3.5

3.6689

0.007

LH (mIU/ml)

7.2235

3.8

6.9

3.2

0.266

Testosterone
(ng/ml)

5.807

4.877

4.743

4.491

0.071

Vitamin D
(25-OH)
(nmol/L)

Groups formed on the basis of semen analysis performed during the study.
Normal Sperm Parameters: total sperm count > 39 million sperm per ejaculate.
motility > 40%, and normal morphology ≥ 4%.
Altered Sperm Parameter Group had at least one of the following:
total sperm count < 39 million sperm per ejaculate.
motility < 40%, and normal morphology < 4%.
p < 0.05 considered significant using Mann Whitney U test.
RPL, Rapid Linear Progression; MORPH, Morphology; FSH, follicle stimulating hormone;
LH, luteinizing hormone.
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TABLE 1B | Comparison of fertile and infertile subgroups having “normal” and “altered sperm parameters.”
Variables

Fertile (135)
Normal sperm
parameter
(n = 93)
Median

Infertile (178)

Altered sperm
parameter
(n = 42)

IQR

Median

P-value

IQR

Normal sperm
parameter
(n = 93)
Median

Altered sperm
parameter/s
(n = 85)

IQR

Median

P-value

IQR

Age (Years)

37

9

37

10

0.084

33

6

33

6

0.654

Sperm count (Million
spermatozoa/
ejaculate

110

60

50

52

0.000

110

60

20

48

0.000

Motility (%)

71

5

50

30

0.000

71

5

35

47

0.000

RLP (%)

1

3

0.5

1

0.083

1

3

0

1

0.000

MORPH (%)

6

6

2

2

0.000

6

6

1

2

0.000

Vitamin D (25-OH)
(nmol/L)

99.22

18.15

89.35

19.92

0.001

61.72

18.15

51.85

20.1

0.000

FSH mIU/ml

6.35

4.6

6.85

2.20

0.418

3.106

2.2

2.8

1.27

0.024

LH (mIU/ml)

9.7

2.13

9.5

2

0.457

6

4.4

6.39

2.84

0.030

Testosterone (ng/ml)

8.04

1.40

8.18

0.87

0.867

3.32

3.20

3.78

2.363

0.146

Normal sperm parameters: total sperm count > 39 million sperm per ejaculate.
motility > 40%, and normal morphology ≥ 4%.
Altered sperm parameter group had at least one of the following:
total sperm count < 39 million sperm per ejaculate.
motility < 40%, and normal morphology < 4%.
RPL, Rapid Linear Progression; MORPH, Morphology; FSH, follicle stimulating hormone; LH, luteinizing hormone.
p < 0.05 considered significant using Mann Whitney U test.

The role of 25OHD on reproductive hormones can be supported
by a significant positive correlation of testosterone with 25OHD.
Our results are consistent with a few other studies that found a
positive correlation between 25OHD and testosterone (10, 22, 23)
while inconsistent with a few others (7, 24). A Korean study
reported that low 25OHD level (< 20 ng/ml) was linked with
an augmented risk of testosterone deficiency (10). Based on the
positive relationship between 25OHD and testosterone, it can be
assumed that harmful effects of higher or lower 25OHD level on
the process of fertility could be interceded by the testosterone.
Researchers have reported higher FSH and LH levels in infertile
patients (11) while few studies described no correlation between
25OHD and reproductive hormones (3, 6). The high LH and FSH
levels in “normal sperm parameters” and the correlation between
25OHD and reproductive hormones signify that 25OHD l plays
a crucial role in the fertility mechanism.
We have found a significant association of 25OHD with sperm
motility. It is not clear how the 25OHD influences the sperm
motility and morphology. It is done either by direct action or
under the influence of reproductive hormones. Still, there is a
gap in the knowledge regarding its exact mechanism of action
on sperm parameters. Several aspects are uncovered and thus not
understandable. Sun et al. proposed that the relationship between
25OHD and sperm motility and morphology might not be due
to the direct action of 25OHD, but it exerts this action via ion
homeostasis (25).
As far as clinical studies are concerned, available data
is limited. An experimental Chinese study reported that
in idiopathic oligoasthenozoospermia, 25OHD treatment

serum 25OHD level was positively associated with progressive
sperm motility and TC in infertile patients (11). He did not
find any significant relationship between serum 25(OH)D3 or
1,25(OH)2D3 with reproductive hormones, despite low 25OHD
levels among different categories of infertile subjects and its
relationship with TC and progressive motility. It seems the
relationship of 25OHD with sperm parameters is independent of
the reproductive hormones.
In infertile males with severe oligoasthenoteratozoospermia
along with deficient vitamin D 25OHD levels, pregnancy
outcomes have been found to be compromised if serum
concentration should fall below 50 nmol/L (20). In our study,
we observed that increased TC, motility and normal morphology
was significantly high in the group of male subjects who had
sufficient 25OHD levels. Numerous studies (human and animal)
have reported the importance of 25OHD in male fertility. It
has been postulated that 25OHD actions are mediated by the
presence of VDR and metabolizing enzymes in the adult male
reproductive tract, male germ cells, and Leydig cells, which are
the major places of testosterone production in men (2, 21).
Blomberg Jensen et al. reported that serum calcium is
imperative for spermatogenesis, sperm motility, and the
acrosome reaction and 25OHD is a key regulator of the calcium
and phosphate homeostasis (3). It may be hypothesized that
25OHD has a dual role in human reproduction and exert its
function by maintaining calcium and phosphate homeostasis and
by influencing sex hormone synthesis (3, 10).
We observed higher levels of testosterone, FSH and LH levels
in the fertile cohort especially with “normal sperm parameters.”
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FIGURE 3 | Comparison of sperm parameters according to Vitamin D status. Mean value compared using Tukey HSD test.

TABLE 3 | Regression analysis showing relationship of Vitamin D (25OHD) with
sperm parameters in the study cohort.

TABLE 2 | Correlation of vitamin D (25OHD) with sperm parameters and male
reproductive hormones in the study cohort.
Parameters

Vitamin D

p-value

Age (Years)

r-value

0.351

<0.05*

Total sperm Count
(Million
spermatozoa
/ejaculate

r-value

0.250

<0.05*

Motility (%)

r-value

0.429

<0.05*

Morphology (%)

r-value

0.308

<0.05*

RLP (%)

r-value

0.067

0.234

FSH (mIU/ml)

r-value

−0.097

0.085

LH (mIU/ml)

r-value

−0.321

<0.001*

Testosterone
(ng/ml)

r-value

0.637

<0.001*

Regression coefficients
Parameters
Total count

Standard error

t-value

p-value

−0.004

0.012

−0.374

0.708

Motility

0.151

0.030

5.083

<0.001*

Morphology

20.148

15.705

1.283

0.201

Dependent variable: Vitamin D, model was adjusted with BMI.
Adjusted R-square = 20%, *p < 0.05 considered significant.

live birth and serum inhibin B in oligozoospermic males as well
as an increase in spontaneous pregnancies as well (29). Such
results show the clinical importance of vitamin D supplements
in vitamin D-deficient infertile male subjects. However, the
discrepancy in clinical data demands further longitudinal
experimental studies on a larger scale with a large sample size to
explore the precise role of 25OHD in male infertility.

* P < 0.05 was considered significant using Pearson’s correlation.
RPL,Rapid Linear Progression; MORPH, Morphology; FSH, follicle stimulating hormone;
LH, luteinizing hormone.

LIMITATIONS

significantly increased the proportion and count of progressively
motile sperm and conception rate (26). A double-blinded
randomized clinical trial reported the absence of any significant
treatment effect of vitamin D3 on serum testosterone levels in a
group of healthy men (27). Another clinical trial found significant
improvement in metabolic profile, serum testosterone levels, and
erectile function in middle-aged vitamin D, 25OHD-deficient
men after 1-year treatment with vitamin D (28). Additionally,
a recent triple-blinded, randomized clinical trial reported that
semen quality parameters did not change in 25OHD-insufficient
infertile men despite the intake of high doses of vitamin D
preparations. However, there was an increase in the chances of

Frontiers in Endocrinology | www.frontiersin.org

Beta coefficient

The study was conducted on a small cohort as far as subgrouping
of infertile subjects in which lifestyle influences, the status
of smoking, screening by DNA Fragmentation Index (DFI),
calcium and phosphorus levels, and Parathyroid hormone status
were not estimated. Furthermore, our study neither noted the
seasonal differences in 25OHD levels among either group nor the
influence of 25OHD on seasonal semen variations. Moreover, we
did not look at the genetic polymorphism of Vitamin D receptors
or Vitamin D binding protein responsible for the decreased
25OHD levels.
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STRENGTHS

vitamin D (25OHD) level in males could result in successful
conception. Therefore, its inclusion in the treatment regime
of infertility should be considered. It will now be of interest
to evaluate the effect of Vitamin D supplementation in this
population of Pakistani men and stratify semen profile outcomes
according to the degree of deficiency.

In the era of increased deficiency of 25-OHD, our study high
lights its importance in acquiring normal sperm parameters thus
leading to fertility. The study also compares semen analysis
performed in both fertile and infertile males.
In a study done to observe effects of vitamin D levels
on pregnancy outcome after intracytoplasmic sperm injection
(ICSI), researchers observed that “deficiency of 25-OHD in
females hinders the accomplishment of optimal endometrial
thickness required for implantation of embryo after ICSI.” The
improvement in vitamin D status can thus improve success
results in assisted reproductive clinics (30). However, the
literature on Vitamin D leaves current knowledge “uncertain”
partly because studies on males or females often fail to consider
the total fertility picture where variables across the gender
profile need to be factored in if we are to obtain the clearest
picture.
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CONCLUSION
The impact of 25OHD levels on sperm parameters can be
emphasized on the basis of detection of its high serum levels
in “normal” subjects in both fertile as well as infertile males.
Our results showed significantly lower levels of 25OHD in
infertile men who had “altered sperm parameter/s” stated in
terms of reduced TC, motility, and/or normal morphology. The
considerably positive association between 25OHD, testosterone,
total sperm count, motility, and morphology likewise accentuates
its impact on normal spermatogenesis and the male reproductive
functions required for acquiring fertility. In light of our results,
it can thus be concluded that reduced 25OHD levels in infertile
male subjects disturb normal physiological mechanisms required
for being fertile, and it is possible that corrected or improved
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